–
Статьи в журналах
-
- 2026 Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in BRAF metastatic melanoma: updated 4-year OS analyses
- Samoylenko I.V., Kolontareva Yu M., Kogay E.V., Zhukova N.V., Utyashev I.A., Ivannikov M.E., Menshikov K.V., Zinkevich M.V., Orlova K.V., Vakhabova Yu V., Volkonskiy M.V., Beliaeva N.A., Shmalts E.A., Karabina E.V., Moskovkina T.L., Moshkova K.A., Plishkina O.V., Sychev V.D., Cheplukhova O.S., Chernova V.V., Yurchenkov A.N., Babina K.G., Savelov N.A., Demidov L.V.
- в журнале Медицинский совет, издательство ООО "Группа Ремедиум" (Москва), № 21, с. 110-122 DOI
-
- 2024 Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study
- Samoylenko Igor V., Kolontareva Yulia M., Kogay Ekaterina V., Zhukova Natalia V., Utyashev Igor A., Ivannikov Mikhail E., Menshikov Konstantin V., Zinkevich Maxim V., Orlova Kristina V., Vakhabova Yulia V., Volkonsky Mikhail V., Beliaeva Natalia A., Butkov Ivan I., Karabina Elena V., Moskovkina Tatyana L., Moshkova Kseniya A., Plishkina Olga V., Sychev Vitaliy D., Cheplukhova Oxana S., Chernova Vera V., Yurchenkov Alexandr N., Babina Ksenia G., Savelov Nikita A., Demidov Lev V.
- в журнале Frontiers in oncology, издательство Frontiers Research Foundation (Switzerland), том 14 DOI